SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike who wrote (1762)8/10/2003 9:16:21 PM
From: Harold Engstrom  Read Replies (2) of 3044
 
Mike, you spammed up SI a few months ago about MDCO being the next big thing and was rude as hell to anyone who didn't want to drink your kool-aid. By June you said you would have your "bing" (you said, "as in bada-bing") but no bing is to be had. Sure, revenues do look like they will be $75MM+, but $100MM looks like a dream for 2003. And the company does not spell out in there release what percentage of revenues is Angiomax - so $100MM for Angiomax may be even more of an unlikely wish than is immediately apparent.

There is still the game to be played so while Angiomax may do OK, there is no guarantee that it will do well enough for MDCO to make any porfit or enough profit to justify its current price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News